Prognosys: Molbio Diagnostics acquires majority stake in Prognosys Medical Systems

Prognosys builds radiology and fluoroscopy solutions under the brand name PRORAD at its facility based out of BengaluruMolbio Diagnostics has acquired a 70 per cent stake in Bengaluru-based Prognosys Medical Systems, manufacturer of the Prorad range of Digital X-Ray units and C-arms and developer of a comprehensive digital health platform.The acquisition further strengthens Molbio's vision of taking health care to the people and adds one more significant weapon to its armoury to help India and the rest of the world, battle deadly communicable and non-communicable diseases.Prognosys builds radiology and fluoroscopy solutions under the brand name PRORAD at its facility based out of Bengaluru that complies with national and international regulatory requirements such as CDSCO, BIS, AERB, EN ISO 13485, European CE and US FDA.The recent introduction of the unique PRORAD Portable and Ultra-Portable digital x-ray units manufactured, for the first time in India, by Prognosys, can deliver high-quality chest images combined with Artificial Intelligence (AI) driven algorithms for automated interpreting and reporting at the point of care. The combination of PRORAD and Truenat system offers a game-changing solution for screening and confirming large populations for highly contagious and devastating diseases such as TB, covid and other ...